Keynote Presentation: Uncovering Clinical Advances with thyTregs™ to Expand the Frontiers of Treg Therapy
- Unveiling clinical data on Thytech’s thyTregs™ therapy preventing transplant rejection in heart transplant children
- Exploring thymic-derived allogeneic Treg therapeutic potential across multiple
- indications including Chron’s disease
- Discussing the escalation capacity of thyTregs™ to accelerate therapeutic success